Affirm Prone Biopsy System

​

What are you looking for in a prone breast biopsy solution? The power to conduct both 2D and 3D™ Breast Biopsies with a single system? Superior imaging equal to today’s most advanced mammography systems? A faster, easier way to work? Full 360˚ access to the breast? The power to improve your patients’ biopsy experience?

​

The Affirm™ prone breast biopsy system delivers it all.

​

The Affirm™ prone biopsy system expands Hologic's breast biopsy portfolio to include a dedicated prone biopsy system, complementing Hologic’s 3D MAMMOGRAPHY™ technology and Affirm™ upright biopsy accessory for the Selenia® Dimensions® mammography system. This portfolio equips hospitals and imaging centers with the options necessary to provide minimally invasive breast biopsies for a wide spectrum of patients.

​

In breast biopsy, superior image quality and superior access are paramount to making it fast and easy to identify and confidently target lesions. We understand that the prone biopsy systems of the past can’t keep up with today’s state-of-the-art mammography systems.

​

That’s why the scientists at Hologic created the world’s first dedicated prone stereotactic biopsy system capable of both 2D and tomosynthesis-guided procedures. This new-generation solution elevates prone biopsy performance to a level never before possible.

The Affirm™ prone biopsy system delivers:

​

• Stereotactic biopsy with Superior 2D or 3D™ imaging using the same proven detector technology found in our Selenia Dimensions mammography system

• A streamlined workflow designed to deliver faster procedures

• Easy, total access to the breast with full 360-degree access and an exclusive fully integrated lateral needle approach to facilitate reaching challenging lesions

• Enhanced patient comfort through ergonomic design and an array of patient positioning aids

 

Hologic’s 3D™ Breast Biopsy option helps visualize lesions that are only seen under tomosynthesis while also reducing the number of steps needed for a procedure and lowering the radiation dose compared to a traditional 2D biopsy.

​